-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
China Biopharmaceutical Co.
Currently, lung cancer is the number one malignant tumor in China in terms of morbidity and mortality.
The Fc receptor and complement-mediated utility of Paampril are completely eliminated by mutations in the Fc region.
Paimrizumab was jointly developed and commercialized by a joint venture established by Kangfang Biological and China Biopharmaceutical Co.
Stomach cancer
State Drug Administration Bureau in May 2020 accepted to send Puli monoclonal antibody for the treatment after at least a second-line systemic chemotherapy relapsed or refractory classical Hodgkin lymphoma (r / rcHL) of the New Drug Application.
Manage lymphoma leave a message here